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Abstract
During 2014–2017, a survey concerning risk factors for cervical cancer involving
1166 clinically healthy women and 65 having CaCx was conducted in Western
Kazakhstan. Only 34.7% of interviewees constantly participated in state-sponsored
screening program, while 37.3% ignored screening in free state-sponsored clinics.
Favorable attitude toward vaccination stated 22.9% of the respondents, whereas
38.8% knew nothing, and 33.6% could not clarify their position in this issue. Edu-
cation is a key factor for better perception of preventive measures—69.2% of the
respondents with higher education are aware of vaccination (p ≤ 0.00001, Cramer’s
V 0.18, χ2–23.1). Social profiles of HPV-infected and CaCx-diseased women differ
significantly and, mainly, by standard of living and occupational status. The likeli-
hood of the CaCx onset in Western Kazakhstan decreased by 14 times at relatively
high standard of living (OR 0.0713, p = 0.024) and by 3.3 times provided at least
irregular participation in screening (OR 0.3384, p = 0.0304). Overall, the findings
are quite able to contribute to an understanding why women become affected by
CaCx. Low standard of living due to lack of education, low attendance of screening,
and low awareness on preventive measures‑all these reasons are interacted and
constitute a set of universal triggers for vulnerability toward CaCx.
Keywords: cervical cancer, human papillomavirus, awareness, vaccination,
screening, risk factors, Kazakhstan
1. Introduction
For cervical cancer (CaCx), the number of diagnoses could “rise by at least 25%
to over 700,000 by 2030, mainly in low- and middle-income countries,” said a
statement from the Lancet [1]. Some sources mention areas of Western Asia as
countries with the lowest CaCx rates [2], while just a few sources are available on
the disease-related issues in borderline Central Asia, where Kazakhstan and some
other post-Soviet states are located [3, 4]. Reportedly, the annual incidence rate of
cervical cancer for Kazakhstan was calculated as 14.5  0.3 with 8.0  0.1 mortality
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for the period 1999–2008 [5]. Data of the International Agency for Research on
Cancer (IARC) on cervical cancer incidence in 2012 for the global network resource
Cancer Today (formerly Globocan) indicated the highest incidence of CaCx in the
Republic of Kazakhstan among borderline countries—29.4 per 100,000 of the
female population standardized by age, while the corresponding index for the
Russian Federation was 15.3, for Uzbekistan 13.5, and 7.5 for China, respectively
[6]. Despite definite progress achieved, issues of cervical cancer prevention have
still remained tense in the country. According to data of the ICO Information
Centre on HPV and Cancer (the Catalan Institute of Oncology HPV center) as of
December 23, 2015, there were 6.72 million women aged 15 years and older at risk of
developing cervical cancer, and estimates indicated that every year 2789 women
were diagnosed with cervical cancer and 982 died from the disease [7]. Morbidity,
according to the ICO experts, has been roughly estimated 32.8 per every 100,000
women standardized by age, i.e., increased several times as many for the period less
than a decade. Meanwhile, cervical cancer is a real object for early detection because
of its belonging to a number of visual forms and can be largely prevented by both
effective screening and vaccination [8].
A system of the cervical cancer screening has been implementing in our country
since 2008, and in frames of this nationwide program, all women aged 30–70 years
are subjected to mass cytological examination every 4 years. Age of women has
been increased from 60 to 70 years, and the interval has been diminished from 4 to
5 years according to the latest regulation no. 995 as of December 25, 2017. With that,
screening coverage (attendance), which had been about 72% for the first years upon
implementation [3], i.e., in line with the WHO recommendations, then began to
decline, reaching about 50% by the present time, as leading scientists of KazIOR
(Kazakh Research Institute of Oncology and Radiology) recorded.
Furthermore, the other large problem is related to the CaCx screening routine in
the country. To date, the majority of specialists in management of women with
atypical cytological results are guided by the joint recommendations of the ACS
(American Cancer Society), ASCCP (American Society for Colposcopy and Cervical
Pathology), USPSTF (US Preventive Services Task Forces), and other leading insti-
tutions [9]. Regrettably, these recommendations still have not been adopted by the
health policymakers in our country, despite the existing HTA (Health Technology
Assessment) reports and leading experts’ opinions confirming advantages of HPV-
based screening in a co-testing way, i.e., collectively with cytology [10–14].
To implement worldwide-accepted screening in a co-testing way, any countries
should first create their nationwide maps of HPV prevalence and type distribution,
as HPV is an apparent causative factor for the CaCx development, and its various
types differ by carcinogenic potential [15–19]. And meanwhile, data on HPV lead-
ing types across Kazakhstan still are limited with a few publications, and far not all
the regions have been studied [20–23]. Currently, 14 types are referred to as the
types of highly carcinogenic risk (HR-HPV) [24]. Listed researches on HPV preva-
lence reported high dissemination of HR-HPV types, within 25–28.3% across exam-
ined regions.
According to world’s leading experts’ opinion, only implementation of universal
HPV vaccination with enhanced screening would maximally reduce the burden of
cervical cancer in post-Soviet countries, albeit options for reducing the HPV-related
disease burden are resource-dependent [4].
Revised in Melbourne (2014), the WHO tactics on the CaCx prevention has
confirmed that HPV vaccination of girls aged 9–13 years still remains the primary
principle of prevention [25].
High rates of cervical cancer along with wide dissemination of HR-HPV types in
Kazakhstan entail the need to renew the state-scale program of universal
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compulsory vaccination of adolescents. Successfully launched in Kazakhstan in
2013, a pilot vaccination program then was discontinued, largely due to the negative
attitude of parents who were not yet ready to the challenges of modern world.
However, further efforts are needed to overcome prejudices in primary prevention
of cervical cancer. According to the estimates of specialists, stated in the press
release of the Centers for Disease Control and Prevention (CDC), in the USA there
was an impressive decrease in the prevalence of vaccine types of HPV by 56% in the
group 14–19 years old for 7 years of the introduction of vaccination against cervical
cancer in adolescent girls (2006–2013) [26]. Recommendations for vaccination are
developed by the world’s leading cancer institutes not only for girls but also for boys
11–12 years old. Effectiveness of vaccination now is convincingly proven and is no
longer questioned [27].
Thus, a wide circle of issues on the CaCx prevention is to be solved in
Kazakhstan in the nearest time, and specific information of the relatively
targeted audience of these efforts would serve as a basis for positive changes in
this direction.
2. Risk factors for HPV infection and cervical cancer development
According to WHO and CDC, the following conditions are considered the risk
factors for the cervical cancer development:
• Inaccessibility of the screening program or rare participation in it.
• Persistent HPV infection.
• States causing immunosuppression, such as HIV, high-dose steroid use, etc.
• Lower genital tract neoplasia irrespective of the area: vulvar, vaginal, and anal.
• Increasing the number of sexual partners (increases risk of HPV acquisition)
along with early age of sexual debut.
• Presence of sexually transmitted infections, such as C. trachomatis and possibly
herpes simplex virus (HSV).
• Tobacco smoking (current and, to a lesser extent, past tobacco smoking)
increases the risk of cervical squamous cell carcinoma.
• The use of birth control pills: long-term use increases the risk of cervical
squamous cell carcinoma.
• More than three full-term pregnancies.
It is worthwhile to emphasize that the risk factors for HPV infection do not
coincide in full with the risk factors for cervical cancer. Only persistent HPV
infection constitutes fundamental condition for the CaCx development, while other
mentioned risk factors such as smoking play a supporting role [13, 28].
To our knowledge, the peak incidence of HPV infection occurs in 20-year-olds,
the peak incidence and detection of CIN-III is characteristic for the age group of
30-year-olds, and the peak incidence of cervical cancer occurs at the age of
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40 years or more. According to estimates, cervical cancer can occur in about 3–5%
of women with high-risk HPV infection unless secondary prevention (screening)
implements [29].
3. Survey as an instrument to get information
Survey, being the most cost-effective and quick tool to recognize needs, inten-
tions, and perception of the targeted audience, serves for specific purposes, but its
design depends not only on the aims claimed but often on standard of living and
concomitant features of the sample tested, such as educational level, availability and
quality of healthcare, etc. One may observe quite noticeable differences in designing
the surveys depending on economic status of the countries where those tools applied.
Mostly, in high-income countries, more detailed surveys designed to reveal more
complex context are used, due to relatively long practicing. For example, in Italy,
surveys aimed for obtaining baseline data on risk factors have been widely practiced
for at least 30 years [30]. Besides, in high-income countries, web-based survey, or
computer-aided self-administered interviewing (CASI), appears to be frequently
used, as well as applying mail and telephone surveys, due to providing better confi-
dentiality for an individual, despite relatively low response rate (65% considered
acceptable) [31–33]. Personal interviews usually are conducted upon facing “difficult
cases,” i.e., where obtaining complex information is needed. Direct interviewing
provides opportunities for best control, surveillance, and on-site verification. Mean-
while, direct interviewing, being a relatively expensive and time-consuming way to
obtain data, nonetheless, applies more frequently in low-/middle-income countries,
where there are many illiterate or low-educated people or in sites where sociocul-
tural customs, different from western lifestyle, are practiced [34–36]. Overall, all
these generalizations are quite arbitrary, as specialists choose a way of operating
mostly based on purposes and capabilities of their research.
As to the models for questionnaire development, the two most cited and used
approaches seem to be most popular, according to literature sources.
One of these approaches constitutes a conception of the Theory of Planned
Behavior (TPB) as applied to the behavioral researches on cervical cancer issues
[32, 37, 38]. According to the theory, the author Ajzen I. stated, “a more favourable
attitude makes a person more attentive toward a recommendation made by signif-
icant others” [39].
The second approach refers to the Health Belief Model, on the basis of which
Robert DeVellis developed guidelines summarized in his book Scale Development.
Based on these guidelines, a principally new questionnaire, CPC-28, has been
developed by Maria Teresa Urrutia and R. Hall [40]. The questionnaire includes six
domains: “the barriers to take a Pap test,” “the cues to action,” “the severity,” “the
need to have a Pap test,” “the susceptibility to cervical cancer,” and “the benefit”
domain. CPC-28 has been used by many researchers as an example for development
of their own questionnaires [41, 42].
These approaches suggest development of questionnaires aimed to reveal per-
ception, intentions, beliefs, and possible attitudes of the individual tested. As
applied toward HPV infection and cervical cancer issues, such models gave a lot
to reveal prejudices relatively CaCx preventive measures—screening and
vaccination—throughout almost all strata of the female population.
The following step in the questionnaire developing is testing for validation
purposes, often including “pretest-test-retest” stages. Testing is the key factor for
checking the tool’s validation and reliability. Usually, outer experts are involved to
check the questionnaire. Field-testing in specially selected representative groups for
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the trial interview purposes is combined with the testing of its internal consistency
by Cronbach’s alpha coefficient. During the trial interviews combined with
Cronbach’s alpha calculation, the amount of items may be changed. For example, in
CPC-28 53 initial items then were decreased to 28, and other researchers reported
cutting down their items from 69 to 26 in order to reach optimal Cronbach’s alpha
within 0.7 and higher [43]. It should be noted that when evaluating the survey
specific results, it is not appropriate to rely on Cronbach’s alpha index solely.
Reliability of the interviewees’ responses does not depend on Cronbach’s alpha
directly. In listed researches the number of items varies from 12 [36] to 26–29
[32, 40, 43] and up to 64–65 [41, 44].
A separate domain of surveys concerning CaCx is presented by studies
addressing the issues of quality of life (QoL), information needs, sexuality, and
other problems in patients with cervical cancer or its precursor, who had undergone
the treatment [45–49].
Overall, creating an effective tool allows for obtaining a lot of valuable data for
timely renewal of cervical cancer prevention strategies, including issues of selecting
the most rational information sources for the targeted audience.
4. The survey on cervical cancer risk factors conducted in Western
Kazakhstan: aims, methodology, and findings
Findings of the survey presented below are quite indicative and to a definite
extent may reflect the current situation with awareness of the CaCx preventive
measures not only in Kazakhstan alone but, in a broad sense, in post-Soviet Central
Asian states.
General information about the country: the Republic of Kazakhstan is a leading
state in Central Asia and refers to middle-income countries. The country ranks 9th
in terms of territory in the world, 64th in terms of population, and 184th in terms of
density (6.3 per sq. km). The population of the country as of January 1, 2016, is
17,417,673; the ratio of men and women is 48:52%. Share of the population aged
15–65 is 71%. The national composition of Kazakhs is 66.1%, Russians 21.5%, and
other ethnic group. 12.4% (data are taken from the information source of the
Agency of Statistics of the Republic of Kazakhstan). The western region is industri-
ally developed and consists of four large provinces: Aktobe, West Kazakhstan,
Mangystau, and Atyrau. All provinces are involved in oil industry, with the
presence of atomic industry in Mangystau.
4.1 Aims, materials, and methods of the research
During 2014–2017 a multipurpose scientific project on HPV infection and cervi-
cal cancer issues was carried out across the region by the West Kazakhstan
University’s research team.
The interview constituted a part of the mentioned research and aimed to deter-
mine qualitatively and quantitatively a group at risk for possible cervical cancer
development. Therefore, tasks of the survey were the following:
• Identifying women of general female population who are infected with HPV in
order to allocate those who are exposed to the CaCx development risk factors
• Comparing women infected with HPV but not having CaCx and those
diagnosed with cervical cancer by matching, to establish dominant risk factors
in the region
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Design and protocol of the study were approved by the University’s Institutional
Review Board (October 9, 2014). The work was carried out in accordance with the
Helsinki Declaration principles. All participants who signed the informed consent
form were fully informed on the objectives of this analysis.
4.1.1 General sample (clinically healthy women)
In determining the sample size for general female population, the following
points mattered:
• According to a pilot study of the West Kazakhstan University on HPV as of
2014, N for HPV genotyping was 1098 with valid statistical results at the
prevalence HR-HPV 26.04% (p ≤ 0.043) [21].
• Statistical data on the number of urban female population living in western
cities of regional importance and suburbs.
In total, N according to calculations (two-side type I error of p ≤ 0.05, 95% CI)
was counted 1152, of which 417 in Aktobe, 253 in Uralsk (West Kazakhstan), 237 in
Atyrau, and 245 in Mangystau.
Data were collected in medical settings in cities of regional importance, includ-
ing the nearest vicinities. To reach maximally possible scope of female population
and avoid possible bias, all kinds of outpatient clinics were involved: state-
sponsored, insurance, and private ones. Enrollment of women was held either
during their routine visit to the gynecologist, by ads placed in the clinics lobby, or
by the invitation of sentinel specialists. Inclusion criteria for general sample were
the following: age 18–60+ years, resident of Western Kazakhstan of any ethnicity,
and no vaccination history.
The exclusion criteria are nonresidents of Kazakhstan and vaccination history.
HIV status and pregnancy of the first trimester were not exclusion criteria.
4.1.2 Cervical cancer sample
As to the sample size of the patients with CaCx first time diagnosed, the number
of adult (18+) female population of the republic along with the incidence of cervical
cancer in Kazakhstan equaled to 4.8% (data of the Agency on Statistics as of 2013)
was applied in the formula:
N=
p q Z2
∝
N
∆
2
N þ p q Z2
∝
(1)
where Z_ (α) = 1.96 is the critical values of the normal standard distribution for a
given α = 0.05, N is the number of female population of the republic (6,700,000),
p = 0.048 is the incidence of cervical cancer, q = 1–p = 0.952, and Δ = 0.05 is the
sampling error.
According to calculations, the needed sample size was within 67–80.
All consonants to participate in the study were selected among women with
first-time-diagnosed cancer across all regional oncology centers.
Inclusion criteria are any age, any stage of the cancer process, and histological
verification of the diagnosis.
Exclusion criteria are nonresidents of the Western Kazakhstan and presence of
the previous medical intervention—radiotherapy, chemotherapy, and surgical
treatment.
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Qualitative detection and quantification of human papillomavirus were
performed in both samples by PCR real-time method based on the Russian test
systems and equipment (“DNA-Technology” LLC, Russian Federation). Production
of the company “DNA-Technology” was certified (ISO 13485: 2012).
4.1.3 Statistical processing
SPSS Statistics 20 software (IBM, Armonk, NY, USA) and the program Statistica
10 (Dell software, USA) were applied for calculations. For all tests a two-side type I
error of p = 0.05 or less at 95% CI was assumed statistically significant. Nonpara-
metric operational tests were used due to a priori missing a normal distribution. To
identify the dominant risk factors for CaCx development, appropriate statistical
tests were carried out: an analysis of the Pearson χ2 contingency tables to identify
significant links (with the definition of the Cramer’s V criterion), analysis of the
quantitative variables in two independent samples (Mann-Whitney test), and
logistic regression analysis with odds ratio calculation (OR).
4.2 Questionnaire designing and survey conducting
4.2.1 Questionnaire designing
The questionnaire was developed in two languages, Kazakh and Russian
(optional), in a semi-structured manner, with questions, mostly closed, to collect
data reflecting a role of the most known risk factors in the development of CaCx.
Overall, the questionnaire included three conditional domains: the first one
for collecting social/demographic information, such as age, ethnicity, education,
occupation, and family (per capita) income of women who were being interviewed.
This domain also included issues related to the number of pregnancies and the
presence of cervical cancer in close relatives irrespective to the time period, at
present or in the past (not in terms of hereditary, but to assess differences
in perception). The conditional second part of the questionnaire concerned
behavioral/social settings: attitude toward smoking, the number of sexual partners
during life, age of sexual activity onset, and the method of contraception
currently used, with focus on the birth control pills (BCPs). The third conditional
domain included questions devoted to perception of the CaCx preventive measures:
attendance of municipal PHC clinics (in terms of availability of state-sponsored
free healthcare), screening activities, and attitude toward vaccination against
cervical cancer. This part consisted of closed questions, to reveal the women’s
perception of nationwide measures, given a mentioned decreasing of the screening
coverage and discontinuation of the pilot vaccination program in adolescents,
started in 2013. As previously stated, adolescents’ parents perceived the program
mostly negatively.
As to the content of the questionnaire, models described in the literature were
not applied when designing, since all available examples were intended for rela-
tively homogeneous audience, whereas in this questionnaire, the list of questions
was identical both for women from the general sample (i.e., clinically healthy) and
women who were diagnosed with CaCx. Besides, another consideration was
mattered. Such a study was the first in its kind in medical practice of the region and
the country, and its response rate was unknown. So, it was decided to develop a
light version of the tool consisting of 14 most important items. Eventually, this
number of questions did not burden the participants and allowed the stated objec-
tives of the survey to be solved.
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4.2.2 Validation of the questionnaire
Validation of the questionnaire was performed through Cronbach’s alpha (α)
calculation, and findings were summarized in Table 1.
The item “contraceptive use” knocked down the total row due to negative r
(0.06). When removing the item, a total Cronbach’s α increased from 0.53 (bad)
to 0.58, i.e., eventually was recognized “doubtful.” Despite the fact that reliability
properties of the questionnaire did not meet accepted requirements (α 0.07 and
higher), it was decided not to modify the tool for increasing its internal consistency
due to considerations described above. Preliminary testing and retest also were not
performed.
Initial calculation for all items Calculation upon deleting the item
“contraception methods”
Result for the scale, mean = 21.2652 Result for the scale, averaged = 19.7543
Std. dev. = 4.07863 Std. dev. = 3,85,041
N items, 14 N items, 13
Alpha Cronbach, 0.452699 Alpha Cronbach, 0.567090
Standardized alpha, 0.525177 Standardized alpha, 0.578369
Mean interposition correlation, 0.080197 Mean interposition correlation, 0.096674
Items General position
correl (r)
α upon
removal
Items General position
correl (r)
α upon
removal
Age 0.171210 0.430272 Age 0.254605 0.541922
Ethnicity 0.148982 0.441428 Ethnicity 0.146472 0.561391
Education 0.351550 0.376869 Education 0.364908 0.511785
Employment 0.370232 0.346615 Employment 0.396442 0.497283
Income 0.374762 0.378943 Income 0.420856 0.502972
Number of
pregnancies
0.018588 0.464434 Number of
pregnancies
0.021628 0.585372
Close relatives
with CaCx
0.075294 0.451611 Close relatives
with CaCx
0.087969 0.567689
Duration of sexual
life
0.227343 0.415536 Duration of sexual
life
0.301034 0.529433
Number of sexual
partners
0.263014 0.414043 Number of sexual
partners
0.290278 0.536063
Contraceptive use 0.064162 0.568096 Contraceptive use — —
Smoking 0.155715 0.443014 Smoking 0.161773 0.561118
State PHC
facilities
attendance
0.281290 0.407147 State PHC
facilities
attendance
0.292777 0.533949
CaCx screening
attendance
0.015578 0.471991 CaCx screening
attendance
0.020295 0.595756
Vaccination
awareness
0.161580 0.437350 Vaccination
awareness
0.162059 0.558797
Table 1.
Results of Cronbach’s α calculation.
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4.2.3 Allocation of interviewees according to the “per capita income”
Data for the “per capita income” item were taken from the website of the
Statistics Committee of the Ministry of National Economy for the fourth quarter of
2014 (data on the standard of living, www.statgov.kz). The amount of the subsis-
tence minimum determining the poverty line was within or slightly more than 100
USD (according to a currency rate).
Overall, three grades were allocated: from less than 100 USD per month up to
200 USD per capita (category of “poor”), from 200 USD up to 500 USD per capita
(category of “satisfactory income”), and from 500 to 1000 USD and higher (the
category of “relatively well-off people”). Allocation of the respondents in this
questionnaire (“poor,” “satisfactory income,” “well-off”) was made based on
statistical publications on the standard of living formed on the basis of a sample
survey of households and posted on the website of the Statistics Agency of the
Republic of Kazakhstan (“Monitoring of incomes and living standards of the
population in the Republic of Kazakhstan”. Analytical notes of the Agency of the
Republic of Kazakhstan on Statistics of the Department of Labor and Living
Standards. Astana, 2011–2013). Based on the above information, it was decided to
calculate per capita income within the twofold subsistence minimum amounting to
200 US dollars, as a threshold of a relatively satisfactory income, and revenue of
500–1000 USD as a threshold of a conditional “well-off income.”
4.2.4 Survey conducting
Direct interviews have been held on site by the research team without partici-
pation of the local staff for providing a better confidentiality of the information
obtained. To motivate a better veracity, researchers allowed not to indicate a real
name and provided relevant explanations on filling in the most “problematic”
items—smoking, number of sexual partners, and income. At the same time, active
assistance to interviewees when filling in the questionnaire was not permitted.
4.3 Results and discussion
A total of 1166 clinically healthy and 65 having CaCx women were interviewed
across the region. A set of data on the survey across both samples, including
descriptive statistics, is presented in Table 2.
Some obtained data have been cross-checked through the available sources.
Information on such indicators as the age of sexual debut, number of pregnancies,
specific gravity of smokers, and number of women who use BCPs has been
presented in the mentioned report on Kazakhstan by the ICO group on monitoring
cervical cancer [7]:
• Average age of sexual debut in women in the Republic of Kazakhstan—20.7
(20.8 in the present survey)
• Average number of pregnancies—2.7 (3.0 in the present survey)
• Total number of women applying birth control pills—7.1% (4.8% in the
present survey)
• Total number of smoking women—9.5% (10.8% in the present survey)
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Parameters (the
questionnaire items)
Cronbach’s
α for each
item
Detailing General
sample,
N 1166
CaCx
sample,
N 65
Notes
Age categories 0.54 18–29 37.7% 1.5%
30–39 34.0% 21.9%
40–49 17.8% 34.4%
50–60+ 10.5% 42.2%
Average age of the interviewees
General sample:
34.5  9.9 (31.2;36.1, 95% CI)
Range 16.0–63.0
М 33.0 (27.0–41.0 by 25/75 quartile)
CaCx sample:
49.0  12.4 (45.9;52.1, 95% CI)
Range 28.0–80.0
M 47.5 (40.0–58.5 by 25/75 quartile)
Ethnicity 0.56 “Asian” 85.3% 79.7% Representatives of
Turkic-speaking
people
“European” 13.6% 20.3% Representatives of
the Slavic diasporas,
Germans
Other (mostly
Caucasus ethnic
groups)
1.1% — Azerbaijanis,
Dagestanis, Koreans,
etc.
Education level 0.51 School education 31.4% 65.6%
Professional
college
22.9% 17.2%
Higher education
(university)
45.7% 17.2%
Employment 0.50 Not occupied 33.6% 48.4% Unemployed,
housewives, retired
Low-skilled labor 13.7% 26.5%
Medium-sized
proficiency sector
20.7% 9.4%
Highly-skilled
occupations
32.0% 15.6%
Monthly income per
capita
0.50 From less than
100 USD and up
to 200 USD
40.1% 50.0% Category of “poor”
people
From 200 USD
up to 500 USD
39.4% 46.9% Category of
“satisfactory
income”
From 500 to 1000
USD and >
20.5% 3.1% Category of
relatively well-off
people
Total number of
pregnancies
0.59 None 10.7% 3.1% This refers to
childbirth, abortion,
ectopic pregnancy
1–2 36.1% 25.0%
3 and more 53.2% 71.9%
Average number of pregnancies in the history
General sample*:
3.0  2.2; range 0–16;
М 3.0 (2.8–4.4 by 25/75 quartile)
CaCx sample:
4.5  3.3; range 0–14;
M 4.0 (2.0–6.0 by 25/75 quartile)
10
Current Perspectives in Human Papillomavirus
Parameters (the
questionnaire items)
Cronbach’s
α for each
item
Detailing General
sample,
N 1166
CaCx
sample,
N 65
Notes
Presence of close
relatives with CaCx
0.57 Yes 5.1% 9.4% Irrespective to the
time period: at
present or in the past
No 94.9% 90.6%
Age of onset of sexual activity
General sample*:
20.8  3.4
Range 13.0–45.0
М 20.0 (18.0–22.0 by 25/75 quartile)
CaCx sample:
20.3  2.3 (19.4;20.8, 95% CI)
Range 19.0–21.0
M 20.0 (15.0–27.0, 25/75 quartile)
Lasting of sexual life 0.53 0–10 years 47.2% 3.1% Regardless the
marriage or
relationship lasting
11–20 years 29.9% 31.3%
20+ years 22.9% 65.6%
Average lasting of sexual life
General sample:
13.5  9.2; range 1.0–45.0
М 12.0 (6.0–20.0)
CaCx sample:
26.5  10.8 (23.3;29.7, CI 95%)
M 22.0 (7.0–59.0)
Number of sexual
partners during life
0.54 1 partner 64.7% 60.9% Regardless of the
relationship lasting
2–5 partners 28.2% 28.1%
6 and more 7.1% 10.8%
Average number of sexual partners during life
General sample:
2.2  2.9 (1.9;2.7, CI 95%); range 1–30
CaCx sample:
3.0  3.4 (2.1;3.9, CI 95%); range 1–15
Current application of
contraceptive methods
(at the time of
interview)*
— I do not apply 43.8% 89.0% Only the age
category ≤49 years
old was considered
Birth control
pills*
4.8% —
IUD (intrauterine
device)
12.4% 4.7%
Condoms 23.0% 6.3%
Other (tubal
ligation, calendar
method, coitus
interruptus)
16.1% —
Attitude toward
smoking*
0.56 I smoke
(smoked)
10.8% 9.4% Regardless of the
smoking lasting
I do not smoke 89.2% 90.6%
Attendance of
municipal PHC
facilities (outpatient
clinics at the place of
residence)
0.53 I visit constantly 40.7% 31.3%
I visit sometimes,
irregularly
46.3% 39.0%
I do not visit, as I
attend only
private clinics
13.0% 29.7%
Participation in the
nationwide screening
program for cervical
cancer (in state-
sponsored clinics)
0.60 I participate
constantly
34.7% 39.0% Age category <
30 years old was not
considered as not
included in the
screening routine
I participate
irregularly
(missed the last/
28.0% 15.6%
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In another authoritative source [50], published in the framework of the
UNICEF international research and summarizing data of the Republic of Kazakh-
stan on many medical and social indicators, the share of women 15–24 years old
who had sexual intercourses with the “unofficial partner/partners” (promiscuity)
during the last year was 16.6%, while the proportion of smoking women aged
15–49 years—8.4%.
Overall, data from these authoritative sources in fact coincided with those
obtained in the present work, which to a definite extent might indicate reliability of
the information provided by participants of the interview.
4.3.1 Social profile of women infected with HPV in the western region of Kazakhstan
A total of 25% of women from the general sample in frames of the present
research appeared to be infected either with HR-HPV types or with non-HR types
(22.3; 27.7 CI 95%, p = 0.05), N 291. One of the tasks of the present study was to
compare those infected with HPV with those who are not infected in order to
identify links between the risk for HPV infection and social/behavioral parameters.
Results of the analysis are presented in Table 3.
This analysis made it possible to outline the social profile of women infected
with HPV in the western region of the country. These are women with satisfactory
financial status (monthly per capita income 200–500 USD), occupied with highly
skilled work, who had up to five sexual partners and more than three pregnancies in
Parameters (the
questionnaire items)
Cronbach’s
α for each
item
Detailing General
sample,
N 1166
CaCx
sample,
N 65
Notes
previous
examination)
I do not
participate
(ignore, as I
attend
gynecologists in
private clinics
only
37.3% 45.3%
Awareness of
vaccination against
cervical cancer
0.58 I know nothing
about vaccination
38.8% 60.9%
I have heard
about
vaccination, but
do not know how
to percept
33.6% 25.0%
I welcome
vaccination
against cervical
cancer
22.9% 10.9%
I am set against
vaccination/I
consider it
unnecessary/
dangerous
4.7% 3.1%
*An asterisk indicates some indicators of general sample, for which there are republic-wide data from other sources.
Table 2.
Total data for both samples across the region with inclusion of descriptive statistics.
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their history. These women constitute a group at risk for further development of the
process, i.e., persistent infection and possible invasive cancer. Increasing awareness
of CaCx prevention among young women should rank first in making policy
concerning CaCx issues.
4.3.2 Relationship between the level of education and perception of CaCx preventive
measures
Further analysis has been performed with the aim of clarifying the relationship
between the level of education and perception of preventive measures for cervical
cancer. As mentioned before, attendance of state (municipal) PHC facilities implies
accessibility and sufficiency of a national free healthcare. In a broad sense, oppor-
tunity to attend state-sponsored free outpatient clinics is also to be considered as a
prevention of socially significant diseases.
№. Parameter or
potential risk
factor
Achieved level of
significance, p-
value (≤0.05)
Cramer’s
V value
Maximum contribution to the final
statistics, Pearson’s χ2
1 Age 0.062 0.09 —
2 Ethnicity 0.78 0.03 —
3 Education 0.4 0.05 —
4 Employment 0.002 0.11 χ2—18.03
9.1% out of 25.0% HPV-infected are
representatives of highly skilled
occupations
5 Level of per capita
income
0.00007 0.13 χ2—19.1
12.1% out of 25.0%—a group with an
income of 200–500 USD per month per
capita (“satisfactory income”)
6 Number of
pregnancies
<0.00001 0.14 χ2—24.0
11.2% out of 25.0%
had three and more pregnancies
7 Presence of close
relatives with CaCx
0.52 0.02 —
8 Sexual life
duration/age of
onset of sexual
activity
0.062 0.07 —
9 Number of sexual
partners
<0.00001 0.16 χ2—30.7
23.5% out of 25.0% had up to five partners
10 Application of
birth control pills
0.33 Phi
0.00096
—
11 Smoking 0.47 0.02 —
12 Municipal
outpatient clinic
attendance
0.46 0.02 —
13 Participation in
screening program
0.19 0.05 —
14 Awareness of
vaccination
0.54 0.03 —
Table 3.
Analysis of the links between HPV infection and social/behavioral parameters.
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In the general sample (Table 1), only 13% of respondents indicated that they do
not visit state-sponsored clinics at the place of residence, while among respondents
with higher education, this indicator has increased up to 35.1% (p ≤ 0.00001;
Cramer’s V 0.14; χ2–23.1). Only 62.7% of interviewees (34.7% constantly and 28.0%
sometimes) respond to an invitation to visit free screening in state (municipal)
facilities, and 37.3% of respondents do not attend free screening program at all,
preferring either opportunistic screening in private physicians or not undergoing
Pap test at all. Among the educated subjects, this indicator has increased up to 51.3%
(p = 0.002, Cramer’s V 0.1, χ2–18.1). Among respondents in the general sample,
40.7% regularly visit the state PHC facilities, but only 34.7% of all interviewees
treat toward screening activities responsibly.
More than two-thirds (69.2%) of subjects with higher education are aware of
vaccination against cervical cancer (p ≤ 0.00001, Cramer’s V 0.18, χ2–23.1),
whereas in the total sample, this figure amounted to 56.5% (33.6% have heard, but
cannot clarify their attitude—positive or negative, 22.9% are aware and welcome).
Ideally, close to 100% of educated subjects of this research had to welcome mass
screening and nationwide immunization program against cervical cancer. For
example, according to a large-scale survey conducted in Brazil (n = 54,000), a high
correlation was found between the level of education/standard of living and the
attendance of mammography and cytology (Pap test): up to 70–80% of educated
interviewees constantly visited screening events—r = 0.52 and r = 0.66, respectively
[51]. In general, Kazakhstan belongs to a group of countries with high Human
Development Index (HDI). According to the results of HDI evaluation in 2016 [52]
when these data were collected, our country ranked 56th in the international rating
between Belarus and Malaysia.
Given the relatively high HDI of the country with a large stratum of enlightened
women, the findings suggest that measures for primary (vaccination) and second-
ary (screening) prevention of cervical cancer are insufficient and do not meet the
needs of population, especially of its educated part. The same applies to situation
with municipal PHC facility attendance (35.1% of educated subjects avoid visit and
51.3% of them avoid free screening there). In this context, relatively low attendance
found in the present survey in educated population can be indicative of unsatisfac-
tory quality of services, which eventually may result in bringing down a prestige of
the national healthcare.
4.3.3 Overall awareness of CaCx preventive measures: role of information sources
Overall awareness of the broad circle of the issues on CaCx prevention varies
depending on the countries, age groups, and education level. Though 71–78% adults
aged 50–70 in England knew that the main aim of the screening programs was to
catch cancer early, but only 18% of them were aware that cervical screening is
primarily preventive [53]. The low level of Pap screening awareness was found
among the students in South Korea [32], about 65% female Saudi teachers were
considered less-knowledgeable about CaCx risk factors [33], only 13% of
interviewed Uyghur women heard about vaccine against CaCx [34], and 30.1% of
female students in Poland were unaware of vaccination as a prevention method
[44]. In the present research, the obtained data on awareness of vaccination in
general sample are approximately similar with the mentioned: 38.8% knew nothing
about vaccines against cervical cancer, while 33.6% heard, but could not decide how
to percept it. These findings evidence a deficit of information apprehensible for a
majority of female population.
A trend, to a definite extent confirming the mentioned TPV model, according to
which most of people in issues of health are guided by opinion of significant others
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showing to them more favorable attitude (close relatives, etc.), might be traced in
findings of the present survey. A group of interviewees which collided with cervical
cancer in their families were analyzed in order to compare their awareness with a
baseline level in general sample. Among relatives of women who fell ill or died from
cervical cancer, the awareness of vaccination has reached 76.8% (p = 0.01, phi 0.1,
χ2–6.0), i.е., even higher than in the stratum of highly educated interviewees
(69.2%), which implied that a part of them purposefully had sought information
regarding prevention/treatment of CaCx. These findings involve the issues on
information sources. According to the mentioned survey conducted across the
country’s households [50], a share of women aged 15–24 which use the Internet
(social networks, messengers) is 94.6%, while the proportion of women aged
15–49 years, at least once a week consuming mass media (newspapers, magazines,
radio, TV), is only 16.1%. Results of this research concerning preferences in infor-
mation seeking in young women would be worth to arrange CaCx prevention
awareness campaign via the Internet across the country.
4.4 Cervical cancer-diseased women in the western region of Kazakhstan:
likelihood of the disease onset
A total of 65 women aged in average 49.0  12.4 diseased with CaCx (just
diagnosed and not yet undergoing treatment) have been interviewed during a
survey. Overall description of this sample has been summarized in Table 1. What is
the most inherent to them comparing to the general sample: most of them (65.6%)
have just school education (compulsory for all population in Kazakhstan) vs. 31.4%
in the general sample, the share of the employed in highly skilled occupations is 15.4
vs. 32% in the general sample, only 3.1% of them refer to a “relatively well-off” in
terms of income, a part of them never visited municipal PHC facilities (31.3%) vs.
13% in the general sample, and they never heard about vaccination (60.9%) vs.
38.8% of clinically healthy women, respectively.
In order to reveal the dominant risk factors for cervical cancer and select a
control group, matching was conducted among those infected with HPV but not
affected with cervical cancer and those having CaCx. Matching was carried out in
proportion 1:1 (65 vs. 65), i.e., for each case of the disease, there was one case from
the control group. Selection of the control group for matching was made according
to the age criterion and also with the help of the random number generator, i.e.,
each HPV-infected had equal chances to get into the control group. Thus, 65
respondents from HPV-infected group were randomly selected for analysis to iden-
tify risk factors.
An analysis of the Pearson χ2 contingency tables to identify significant links
(including the Cramer’s V criterion) is shown in Table 4.
Table 5 presents results of the Mann-Whitney test, detailing the analysis of
quantitative variables.
Thus, social profile of women with CaCx was defined: they are mostly aged 50–
60 + years old, in overwhelming majority infected with HPV 16, poorly educated,
unemployed, mostly living within the poverty line, with lasting of sexual life over
20 years, not participating in the screening program, and not aware of the cervical
cancer prevention measures (vaccination). A large number of pregnancies and high
level of viral load also mattered in their profile.
To assess the likelihood of the disease onset, a logistic regression model was
developed. As a “positive effect,” the onset of the disease was accepted, and as a
“negative effect”—the absence of cervical cancer. The logistic regression was
performed by the “forward” method, provided that the variables were introduced,
if p < 0.05, and removed, if p > 0.1. The sample size was 130 cases, where 65 (50%)
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were positive and 65 (50%) were negative ones. The logistic regression model was
evaluated through the Nagelkerke R2 (0.3881, p < 0.0001) and recognized
“working.” Coefficients, standard errors, and a chance, including the odds ratio
(OR), have been calculated by commonly accepted methods, and the risk group for
CaCx begins at a value >40. Results are summarized in Table 6.
Thus, likelihood of the disease onset:
• Decreases by 14 times at a per capita income level of 500–1000 USD
+ (category of relatively well-off)
• Increases by 0.9 times with the lasting of sexual life over 20 years
• Increases by 0.16 times provided lack of attendance in the state (municipal)
clinics
• Decreases by 3.3 times provided at least irregular participation in screening for
cervical cancer
Calculation of the morbidity prognosis based on OR in both groups (HPV-
infected but not affected with CaCx and having CaCx) was performed.
№. Qualitative parameter
or potential risk factor
Achieved level of
p-value (≤0.05)
Cramer’s
V criterion
Maximum contribution to the
summary statistics, Pearson’s χ2
1 Age 0.003 0.29 11.3—age 50–60+
2 Ethnicity 0.5 0.09 1.19
3 Education 0.00075 0.33 14.4—poorly educated
4 Employment
(occupation)
0.00053 0.37 17.6—not employed
(unemployed, housewives,
retired)
5 The level of per capita
income
0.001 0.33 13.6—low income
6 Number of pregnancies 0.23 0.15 2.9
7 Presence of close relatives
with CaCx
0.13 0.13—phi 2.2
8 Sexual life duration 0.007 0.28 9.9—over 20 years
9 Number of sexual
partners
0.19 0.16 3.3
10 Methods of contraception 0.32 0.007 0.0009
11 Smoking 0.97 0.002 0.0007
12 Attendance of the state
clinics
0.09 0.19 4.8
13 Participation in screening
program
0.006 0.28 10.2—not participating in
screening program
14 Awareness of vaccination 0.026 0.27 9.2—not aware of vaccination
15 Type of HPV* 0.00007 0.35—phi 15.9–72.6% of women with CaCx
are infected with typ. 16
* For other genotypes of HPV p-value ≤0.05 has not been revealed.
Table 4.
Results of contingency table analysis.
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Variables U Mann-Whitney test
Criteria are significant at the level of p < .05000
Summary rank CaCx Summary rank control U Z p-Level Z correct. p-Level Two-sided exact p
Age 4931.5 3453.5 1308.5 3.63184 0.000281 3.63469 0.000278 0.000233
Age of onset of sexual activity 3845.0 4540.0 1765.0 1.48147 0.138482 1.49867 0.133960 0.138856
Number of partners 4049.5 4335.5 1969.5 0.51816 0.604346 0.56433 0.572531 0.603861
Duration of sexual life (exposure) 4955.0 3430.0 1285.0 3.74254 0.000182 3.74551 0.000180 0.000148
Number of pregnancies 4595.0 3790.0 1645.0 2.04674 0.040685 2.06837 0.038606 0.040401
Viral load level 4785.0 3600.0 1455.0 2.94174 0.003264 2.94231 0.003258 0.003057
Table 5.
Results of the Mann-Whitney test.
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Overall, prognosis is justified for 73.9% infected with HPV, but not affected by
cervical cancer and for 70.3% for women having CaCx (correctly predicted cases—
72.09%, at a cutoff value of p = 0.5).
4.5 What was learned from a survey on cervical cancer risk factors in Western
Kazakhstan
Based on the data collected in 1166 clinically healthy women, of them 291 (25%)
infected with HPV, and 65 women having cervical cancer, one may conclude that
the main reason for a chance of the CaCx onset is a low understanding on what are
the measures of preventing CaCx.
Only 34.7% of interviewees constantly participate in nationwide screening pro-
gram, while 37.3% fully ignore nationwide screening in free state-sponsored PHC
facilities. Favorable attitude toward vaccination against cervical cancer stated 22.9%
of respondents, whereas 38.8% knew nothing, and the rest 33.6% could not clarify
their position in this issue.
Education is a key factor for better perception of preventive measures—more
than two-thirds of respondents with higher education are aware of vaccination
against cervical cancer (p ≤ 0.00001, Cramer’s V 0.18, χ2–23.1).
And meanwhile, the same stratum of educated women mostly negatively treats
to state-sponsored PHC facilities, avoiding visit (35.1 vs. 13.0% in the general
sample, p ≤ 0.00001, Cramer’s V 0.14, χ2–23.1). Moreover, 51.3% of educated
women avoid nationwide free screening in state PHC facilities (p = 0.002; Cramer’s
V 0.1; χ2–18.1). This fact evidences insufficient quality of medical care in state-
sponsored clinics.
Lack of relevant information on the CaCx in interviewees who had close rela-
tives with CaCx made them seek and eventually reach a higher awareness level
concerning preventive measures—76.8% vs. 56.5 in the general sample (p = 0.01,
phi 0.1, χ2–6.0). These findings evidence a deficit of information apprehensible for
a majority of the female population.
Though a more number of sexual partners contributed to the risk of being
infected with HPV (p ≤ 0.00001, Cramer’s V 0.16, χ2–30.7), but this factor played
no role in the risk of CaCx development. Overall, social profiles of HPV-infected
and CaCx-affected women differ significantly and, mainly, by standard of living
and occupational status.
Social profile of women having CaCx is mostly aged 50–60 + years old, in
overwhelming majority infected with HPV 16 (72.6% of them), poorly educated,
unemployed, mostly living within the poverty line, with the sexual life lasting over
20 years, not participating in the screening program, and not aware of the cervical
Variables Coefficient Std. error Wald p ОR 95% CI
Income per capita 500–1000
USD + (3)
2.64144 0.86882 9.2432 0.0024 0.0713 0.0130–0.3912
Sexual life lasting >20 years (3) 0.083917 0.023797 12.4349 0.0004 1.0875 1.0380–1.1395
Attendance of state clinics
(lack of attendance) (3)
1.80433 0.63020 8.1974 0.0042 6.0759 1.7667–20.8954
Participation in screening
(irregular) (2)
1.08362 0.50041 4.6892 0.0304 0.3384 0.1269–0.9023
Constant 1.69108 0.58494 8.3581 0.0038
Table 6.
Calculation of a chance and OR for the disease onset.
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cancer prevention measures (vaccination). A large number of pregnancies and high
level of HPV viral load also mattered in their profile.
The likelihood of the CaCx onset under conditions of Western Kazakhstan
decreases by 14 times at relatively high standard of living, income not less 500 USD
per capita (OR 0.0713, p = 0.024) and decreases by 3.3 times provided at least
irregular participation in screening for cervical cancer (OR 0.3384, p = 0.0304).
Overall, the findings suggest that measures for primary (vaccination) and sec-
ondary (screening) prevention of cervical cancer are insufficient and do not meet
the needs of the population, especially of its educated part.
5. General conclusion
Findings obtained in this first survey arranged in Kazakhstan are quite general-
izable for post-Soviet Central Asian states and, to a lesser extent, for the over-
whelming majority of Asian developing countries with high incidence of CaCx.
These findings are quite able to contribute to an understanding why women become
diseased with CaCx. Low standard of living due to lack of education, low attendance
of screening, and low awareness on preventive measures, all these reasons, are
interacted and constitute a set of universal triggers for vulnerability toward CaCx.
Kazakhstan is not an exclusion within a wide range of middle-income countries,
which need drastic changes in approach to prevent cervical cancer and in revision of
a set of applied measures. Population-based surveys, being a very effective tool for
studying needs of the targeted audience, should serve as the first step toward
diagnostically optimal and cost-effective updated nationwide program for the CaCx
prevention.
Elaboration and implementation of a new program should focus on a significant
increase of awareness in female population on cervical cancer consequences and a
role of HPV infection as a causative factor.
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